Why next gen alt protein startups will be built on access, not just science

What separates alt protein winners is no longer just cutting-edge technology, but the ability to navigate funding gaps, build partnerships and access the infrastructure required to scale.

Over the past five years, alternative protein has moved from a promising, accessible and sustainable solution for a booming global population to a complex, and often more sobering, reality. Through waves of restructurings, shutdowns and strategic pivots, the sector’s dynamics revealed just how difficult it is to translate early hype into scalable, sustainable business.

Rapid expansion fueled by investor enthusiasm defined the early growth of alternative protein, but many companies struggled to sustain that momentum. Meatless Farm and Plant & Bean both bolstered by venture capital, entered administration in the UK, a process similar to bankruptcy protection in the US. Cultivated meat startup Higher Steaks shut down before its assets were eventually acquired by Meatable last year.

At the same time, meat alternative category pioneers such as Beyond Meat and Impossible Foods have been forced to retrench. The former expanded into the functional beverage space and rebranded as Beyond. The latter focuses on strategic partnerships, like with functional bread brand Equii, centered around protein. Meanwhile, biotech startup Perfect Day, which produces animal-free whey protein via precision fermentation, pivoted away from consumer-facing products to focus its business towards B2B operations.

These shifts reflect a broader reset underway across food tech, one that is forcing companies to combine technological innovation, commercial reality and consumer behavior in a narrower funding environment, according to Daniel Gertner, lead economist and industry analyst for Good Food Institute.

“The alternative protein sector’s evolution over the past five years reflects dynamics we’re seeing across food tech more broadly: a significantly tighter funding environment colliding with a gap between early consumer curiosity and sustained repeat purchases,” he said.

Closing the demand gap where curiosity doesn’t equal conversion

While the first wave of plant-based meat succeeded in generating awareness, trial and cultural relevance at a striking pace rarely seen in food, keeping that momentum afloat has proven far more difficult.

“The companies that have navigated this period most successfully have done the hard work of closing the gap on the two things consumers care about most: taste and price. While consumers may try new foods for their novelty, for them to become repeat customers, the products need to taste good and fit their budget,” Gertner explained.

Products that failed to deliver on taste, texture and health benefits or remained priced at a premium have struggled to retain consumers. This discrepancy is shown through plant-based dairy’s increased market share compared to plant-based meat, which suggests that innovation beyond dairy replication, usage occasions and ingredient simplicity are driving those coveted repeat purchases.

Gertner points to evidence that closing this gap yields meaningful upsides.

“We’ve seen how products that deliver a sensory experience on par with their conventional counterparts can capture meaningfully greater market share, and data from Europe shows that moving to price parity can drive sales volume up 30 percent or more,” he said.

Messaging missteps and missed opportunities

How companies communicated value in the past also shaped outcomes – especially as consumer skepticism around the “techification” of food created confusion around processing and artificial ingredients. This confusion hit brands like Beyond particularly hard as the company invested in reformulation to simplify its ingredient list across its portfolio.

“There’s also an untapped opportunity in how companies communicate their value proposition. Plant-based meat offers differentiated health benefits – like high protein, fiber, low saturated fat and no cholesterol – but most consumers don’t know it yet,” Gertner emphasized.

While investment in branding and marketing can do the heavy lifting in communicating value to consumers, much of the alternative protein sector has struggled to clearly articulate why consumers should make the switch beyond sustainability messaging, according to GFI research.

“Consumers who associate plant-based meat with these positive health attributes spend significantly more on it, suggesting that awareness, not just product quality, is a meaningful purchase driver,” Gertner added.

A larger opportunity still waiting to be unlocked

Despite recent setbacks, the underlying consumer opportunity suggests the sector’s current headwinds may be more of a correction than a collapse.

“The consumer opportunity here is larger than the current sales picture would suggest. Nearly three in four US adults from Gen Z to Gen X are open to or already eating plant-based meat and/or dairy – representing roughly $60 - $70 billion of US retail spend on conventional meat,” Gertner stated.

Gertner points out that growth may hinge more on deepening engagement with consumers already in the category, rather than focusing on capturing entirely new consumers.

“Current buyers purchase plant-based meat only about once a month on average. If these shoppers made just one additional purchase per month, it could unlock roughly $1 billion in additional annual sales,” he said.

Rethinking capital from rapid expansion to structured financing

If consumer dynamics exposed one set of challenges, the shift in funding conditions exposed another.

he more accessible capital from five years ago that fueled rapid expansion across alternative protein transitioned into a much more constrained environment – forcing companies to rethink how they scale.

“On the financing side, companies are increasingly de-risking scale-up and extending runway by combining private investment with public funding, development finance and commercial partnerships,” Gertner noted.

Europe, he points out, offers a model for how this approach can work in practice.

“Europe demonstrates the efficacy of this approach: Public-private mechanisms have helped companies there build a resilient innovation pipeline and, for the third consecutive year, attracted more investment than North America,” Gertner said.

European startups like Germany’s Formo received €35 million (roughly $39 million) from the European Investment Bank to manufacture its animal-free dairy products.

Finland’s Onego Bio, which produces egg-white protein, was developed at VTT (Finland’s state-backed research institute) and supported by a mix of public funding and venture capital.

Although Austria-based Arkeon‘s gas fermentation-derived amino acids landed more than $13 million in private funding, in addition to publicly funded research, it wasn’t enough to successfully scale and the startup filed for insolvency last year.

Manufacturing shortages for precision fermentation production in the US are driving alternative solutions to accelerate the region’s innovation.

US startups like alt-dairy Aux Labs are building their business backwards as a means for sustained, gradual growth. Rather than raising capital to build a pilot facility, Aux Labs is partnering with breweries in North America to inform its ingredient design and scaling strategy. Meanwhile, biotech startup Helaina’s recent partnership with Nestlé signals the corporate sector’s role in scaling and securing the production of proteins, which in this case is Helaina’s precision fermentation-derived lactoferrin (effera) for early-life nutrition.

Academic and corporate partnerships in the US also address manufacturing shortages precision fermentation. Most notably, University of Illinois Urbana-Champaign’s iFAB (Integrated Bioprocessing Research Lab), an Illinois-based accelerator backed by corn commodity players ADM and Primient, which provides pilot facilities for companies testing and refining their production .

A more disciplined second wave

Between the company closures, restructurings and pivots of the past five years, the alt protein sector continues to find its footing across shifting funding dynamics and consumer behaviors. Moving forward, companies’ staying power will be determined by more measured execution rather than a grow-at-all-costs mindset.

“The lesson for startups and investors is that scaling food-tech innovation is rarely a sprint. The companies best positioned to succeed are pairing disciplined execution with patient, diversified sources of capital,” Gertner emphasized.